Bank of New York Mellon Corp - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 140 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.6%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$2,031,630
+159.7%
123,129
-0.5%
0.00%
Q2 2023$782,416
+108.3%
123,800
+11.9%
0.00%
Q1 2023$375,691
-44.5%
110,660
-5.6%
0.00%
Q4 2022$677,301
-84.0%
117,180
-74.0%
0.00%
-100.0%
Q3 2022$4,235,000
-57.7%
450,525
+0.4%
0.00%
-50.0%
Q2 2022$10,014,000
-70.6%
448,829
-27.6%
0.00%
-71.4%
Q1 2022$34,068,000
-22.7%
619,626
-7.1%
0.01%
-12.5%
Q4 2021$44,074,000
-24.7%
666,878
-4.4%
0.01%
-27.3%
Q3 2021$58,554,000
+47.6%
697,560
+123.2%
0.01%
+37.5%
Q2 2021$39,677,000
+15.1%
312,586
-0.5%
0.01%
+14.3%
Q1 2021$34,463,000
-35.8%
314,158
-16.5%
0.01%
-41.7%
Q4 2020$53,698,000
+46.7%
376,121
-27.5%
0.01%
+33.3%
Q3 2020$36,607,000
+9.0%
518,748
+8.0%
0.01%0.0%
Q2 2020$33,599,000
+105.8%
480,116
+2.8%
0.01%
+80.0%
Q1 2020$16,326,000
-41.0%
467,004
+6.1%
0.01%
-28.6%
Q4 2019$27,673,000
+746.0%
440,251
+351.1%
0.01%
+600.0%
Q3 2019$3,271,000
+126.8%
97,591
+75.7%
0.00%
Q2 2019$1,442,000
+331.7%
55,532
+175.2%
0.00%
Q1 2019$334,000
+59.8%
20,182
+4.4%
0.00%
Q4 2018$209,000
-56.2%
19,335
+1.6%
0.00%
Q3 2018$477,000
+41.1%
19,029
+22.3%
0.00%
Q2 2018$338,000
+97.7%
15,553
+32.9%
0.00%
Q1 2018$171,00011,7070.00%
Other shareholders
CARDLYTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders